TAK-285
TAK-285 is a potent, selective, ATP-competitive and orally active HER2 and EGFR (HER1) inhibitor with IC50 of 17 nM and 23 nM, respectively. TAK-285 is >10-fold selectivity for HER1/2 than HER4, and less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. TAK-285 has effective antitumor activity[1]. TAK-285 can cross the blood-brain barrier (BBB) [2].
Product Specifications
CAS Number
871026-44-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/TAK-285.html
Purity
98.99
Solubility
DMSO : ≥ 50 mg/mL
Smiles
ClC(C=C(NC1=NC=NC2=C1N(CCNC(CC(C)(C)O)=O)C=C2)C=C3)=C3OC4=CC=CC(C(F)(F)F)=C4
Molecular Formula
C26H25ClF3N5O3
Molecular Weight
547.96
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
EGFR/ErbB1/HER1; ErbB2/HER2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
E-Cadherin (CDH1) / CD324 (Intercellular Junction Marker) (CDH1/2208R), CF594 conjugate, 0.1mg/mL
![TFIIB (GTF2B) Mouse Monoclonal Antibody [Clone ID: OTI1H10]](https://cdn.genprice.uk/products/937/68dd18ba061270361e908350/imageurl/cf808547.webp)
TFIIB (GTF2B) Mouse Monoclonal Antibody [Clone ID: OTI1H10]
